Literature DB >> 12118389

Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets.

Avraham Eisbruch1, Robert L Foote, Brian O'Sullivan, Jonathan J Beitler, Bhadrasain Vikram.   

Abstract

The head and neck contain many critical, noninvolved structures in close vicinity to the targets. The tightly conformal doses produced by intensity-modulated radiation therapy (IMRT), and the lack of internal organ motion in the head and neck, provide the potential for organ sparing and improved tumor irradiation. Many studies of treatment planning for head and neck cancer have demonstrated the dosimetric superiority of IMRT over conventional techniques in these respects. The initial results of clinical studies demonstrate reduced xerostomia. They suggest an improvement in tumor control, which needs to be verified in larger studies and longer follow-up. Critical issues for successful outcome of head and neck IMRT are accurate selection of the neck lymph nodes that require adjuvant treatment, and accurate delineation on the planning computed tomography (CT) of the lymph-node bearing areas and subclinical disease adjoining the gross tumor. This review emphasizes these topics and provides some guidelines. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Year:  2002        PMID: 12118389     DOI: 10.1053/srao.2002.32435

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  42 in total

1.  [Intensity modulated radiotherapy (IMRT) of head and neck tumors. Increased biological effectiveness in high-risk situations by "integrated boost" therapy].

Authors:  D Milanovic; F Lohr; K Götte; B Dobler; B Hermann; K Hörmann; F Wenz
Journal:  HNO       Date:  2004-08       Impact factor: 1.284

2.  The effect of slice thickness on target and organs at risk volumes, dosimetric coverage and radiobiological impact in IMRT planning.

Authors:  S P Srivastava; C-W Cheng; I J Das
Journal:  Clin Transl Oncol       Date:  2015-08-27       Impact factor: 3.405

Review 3.  Intensity-modulated radiotherapy: is xerostomia still prevalent?

Authors:  Mark S Chambers; Adam S Garden; David Rosenthal; Anesa Ahamad; David L Schwartz; Angel I Blanco; K S Clifford Chao; William H Morrison; K Kian Ang; Randal S Weber
Journal:  Curr Oncol Rep       Date:  2005-03       Impact factor: 5.075

Review 4.  Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer.

Authors:  Avraham Eisbruch; Vincent Gregoire
Journal:  Semin Radiat Oncol       Date:  2009-01       Impact factor: 5.934

Review 5.  Organ-sparing radiation therapy for head and neck cancer.

Authors:  XiaoShen Wang; ChaoSu Hu; Avraham Eisbruch
Journal:  Nat Rev Clin Oncol       Date:  2011-07-26       Impact factor: 66.675

6.  Intensity-modulated radiotherapy vs. parotid-sparing 3D conformal radiotherapy. Effect on outcome and toxicity in locally advanced head and neck cancer.

Authors:  M Lambrecht; D Nevens; S Nuyts
Journal:  Strahlenther Onkol       Date:  2013-01-16       Impact factor: 3.621

7.  Individualized IMRT treatment approach for cervical lymph node metastases of unknown primary.

Authors:  S Janssen; C Glanzmann; G Huber; G Studer
Journal:  Strahlenther Onkol       Date:  2014-02-07       Impact factor: 3.621

8.  Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life.

Authors:  Christopher R Spencer; Hiram A Gay; Bruce H Haughey; Brian Nussenbaum; Douglas R Adkins; Tanya M Wildes; Todd A DeWees; James S Lewis; Wade L Thorstad
Journal:  Cancer       Date:  2014-08-20       Impact factor: 6.860

9.  Clinical outcomes of IMRT planned with or without PET/CT simulation for patients with pharyngeal cancers.

Authors:  Tomohiro Matsuura; Yasumasa Nishimura; Kiyoshi Nakamatsu; Shuichi Kanamori; Kazuki Ishikawa; Izumi Tachibana; Makoto Hosono; Toru Shibata
Journal:  Int J Clin Oncol       Date:  2016-09-07       Impact factor: 3.402

Review 10.  Defining the target for radiotherapy of head and neck cancer.

Authors:  S Nuyts
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.